Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH1243598427
Wed, 05.08.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Basel, 5 August 2026. Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in affordable medicines, today presents its financial results for the first half of 2026 and net-sales performance for the second quarter of 2026.
H1 2026 RESULTS
H1 net sales up by 5% at [ … ]
Mon, 03.08.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
When completed, settlement with 43 US states and territories would mean no remaining US federal or state governmental claims
Separate indirect reseller settlement resolves all remaining class-action litigation related to this matter
No impact on full-year 2026 g [ … ]
Wed, 29.07.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Sandoz has commercial rights in USD 1.8 billion GLP-1 local market; positioned for launch in second half of 2026
More than 16.5 million Brazilians live with diabetes; disease remains key public health challenge in Brazil
Potential to expand patient access to hig [ … ]
Wed, 15.07.2026
Sandoz Group AG
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Pascal Bouye appointed President, Generics Manufacturing & Supply; Glenn Gerecke takes on new role within Sandoz
North America President Keren Haruvi to oversee global M&A activities, in addition to current responsibilities
Transformation & Growth He [ … ]
Thu, 09.07.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Regulatory Admission
Sandoz moves up Swiss equity rankings to join premier Swiss Market Index 09.07.2026 / 07:00 CET/CEST
MEDIA RELEASE
Basel, 9 July 2026 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in affordable medicines, today announces that it will be included in the Swiss Market Ind [ … ]
Wed, 17.06.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Expansion
Sandoz steps up in-house biosimilar capabilities, opening state-of-the-art development centre to capture ‘golden decade’ opportunity 17.06.2026 / 07:00 CET/CEST
MEDIA RELEASE
Marking 20 years since launch of world’s first biosimilar, Sandoz opens new biosimilar development centre in L [ … ]
Fri, 15.05.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Regulatory Approval
Sandoz confirms European Commission approval for biosimilars Bysumlog® (insulin lispro) and Dazparda® (insulin aspart), strengthening position in diabetes 15.05.2026 / 13:00 CET/CEST
MEDIA RELEASE
Biosimilars Bysumlog® (insulin lispro) and Dazparda® (insulin aspart) approve [ … ]
Wed, 29.04.2026
Sandoz Group AG
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASE
Basel, 29 April 2026 – Sandoz (SIX: SDZ/OTCQX: SDZNY), the global leader in affordable medicines, today presents its net-sales performance for the first quarter of 2026.
Q1 2026
%
Q1 2025
Change
[ … ]
Wed, 15.04.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Agreement
Sandoz signs landmark agreement with Rwandan government to ensure stable provision of critical medicines across selected African markets 15.04.2026 / 07:00 CET/CEST
MEDIA RELEASE
Strategic partnership with Rwandan government to directly supply critical medicines, including antibiotics [ … ]
Wed, 18.03.2026
Sandoz Group AG
Sandoz Group AG
/ Key word(s): Agreement
Sandoz announces partnership agreement with Samsung Bioepis on up to five biosimilars, further expanding its leading pipeline to up to 32 assets 18.03.2026 / 08:30 CET/CEST
MEDIA RELEASE
Agreement for up to five biosimilar assets, with potential for further collaboration; first asset [ … ]
